These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28840639)

  • 1. Use of oral antidiabetic drugs in the treatment of maturity-onset diabetes of the young: A mini review.
    Brunerova L; Rahelić D; Ceriello A; Broz J
    Diabetes Metab Res Rev; 2018 Jan; 34(1):. PubMed ID: 28840639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current treatment options in Maturity-Onset Diabetes of the Young].
    Brunerová L; Urbanová J; Brož J
    Vnitr Lek; 2018; 64(4):375-379. PubMed ID: 29791172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy Complicated by the Most Frequent Forms of Maturity Onset Diabetes of the Young: A Narrative Review on Its Pharmacological Implications.
    Gonzalez CD; Perkins VI; de Lima AA; Fogar R; Frechtel GD; Di Girolamo G
    Curr Rev Clin Exp Pharmacol; 2021; 16(3):228-234. PubMed ID: 32914719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Maturity onset diabetes of the young (MODY) - screening, diagnostic and therapy].
    Kaser S; Resl M
    Wien Klin Wochenschr; 2016 Apr; 128 Suppl 2():S204-7. PubMed ID: 27052244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features, complications and treatment of rarer forms of maturity-onset diabetes of the young (MODY) - A review.
    Aarthy R; Aston-Mourney K; Mikocka-Walus A; Radha V; Amutha A; Anjana RM; Unnikrishnan R; Mohan V
    J Diabetes Complications; 2021 Jan; 35(1):107640. PubMed ID: 32763092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maturity onset diabetes of the young: Seek and you will find.
    Heuvel-Borsboom H; de Valk HW; Losekoot M; Westerink J
    Neth J Med; 2016 Jun; 74(5):193-200. PubMed ID: 27323672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY).
    Nkonge KM; Nkonge DK; Nkonge TN
    Clin Diabetes Endocrinol; 2020 Nov; 6(1):20. PubMed ID: 33292863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
    Østoft SH
    Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Options for MODY Patients: A Systematic Review of Literature.
    Delvecchio M; Pastore C; Giordano P
    Diabetes Ther; 2020 Aug; 11(8):1667-1685. PubMed ID: 32583173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stratified medicine for the use of antidiabetic medication in treatment of type II diabetes and cancer: where do we go from here?
    Emami-Riedmaier A; Schaeffeler E; Nies AT; Mörike K; Schwab M
    J Intern Med; 2015 Feb; 277(2):235-247. PubMed ID: 25418285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral treatment of type 2 diabetes mellitus].
    Olsovský J
    Vnitr Lek; 2007; 53(7-8):853-4, 856-8. PubMed ID: 17915430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monogenic form of diabetes mellitus due to HNF4α mutation (MODY-1) - the first case in Hungary].
    Jermendy G; Balogh I; Gaál Z
    Orv Hetil; 2016 Mar; 157(12):469-73. PubMed ID: 26971647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maturity onset diabetes of the young (MODY)--history, first case reports and recent advances.
    Siddiqui K; Musambil M; Nazir N
    Gene; 2015 Jan; 555(1):66-71. PubMed ID: 25281821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three novel mutations in MODY and its phenotype in three different Czech families.
    Bazalová Z; Rypácková B; Broz J; Brunerová L; Polák J; Rusavý Z; Treslová L; Andel M
    Diabetes Res Clin Pract; 2010 May; 88(2):132-8. PubMed ID: 20132997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Maturity onset diabetes of the young: just think about it].
    Messaaoui A; Tenoutasse S; Dorchy H
    Rev Med Brux; 2016; 37(2):95-100. PubMed ID: 27487694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral antidiabetic drugs and regression from prediabetes to normoglycemia: a meta-analysis.
    Phung OJ; Baker WL; Tongbram V; Bhardwaj A; Coleman CI
    Ann Pharmacother; 2012 Apr; 46(4):469-76. PubMed ID: 22474136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs.
    Panicker GK; Karnad DR; Salvi V; Kothari S
    J Assoc Physicians India; 2012 Jan; 60():56-61. PubMed ID: 22715547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of type 2 diabetes mellitus and other specific types of diabetes; its role in treatment modalities.
    Kota SK; Meher LK; Jammula S; Kota SK; Modi KD
    Diabetes Metab Syndr; 2012; 6(1):54-8. PubMed ID: 23014256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.